Thursday 15 March 2018 photo 10/15
![]() ![]() ![]() |
Esc dapt guidelines: >> http://isg.cloudz.pw/download?file=esc+dapt+guidelines << (Download)
Esc dapt guidelines: >> http://isg.cloudz.pw/read?file=esc+dapt+guidelines << (Read Online)
4 Sep 2017 Extending DAPT over a longer period of time may confer benefit in terms of reduction in spontaneous myocardial infarction (MI), albeit at the cost of increased bleeding risk. Thus, the new guidelines propose two risk stratification tools, that have specifically been developed to address the issue of DAPT
5 Sep 2017 ESC 2017 Guidelines and Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease. Hence, we need not only one antiplatelet but dual antiplatelet therapy (DAPT), which has been shown to be beneficial in clinical trials. Hence, DAPT is used post-stenting. Once epithelialization of the
Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Juni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN; ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies.
8 Sep 2017 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease Developed in Collaboration With EACTS: The Task Force for Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).
3 Oct 2017 The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their at: www.escardio. org/Guidelines/Clinical-Practice-Guidelines/2017-focused-update-on-dual-antiplatelet-therapy-dapt.
Dual antiplatelet treatment (DAPT) is a cornerstone of maintenance medication of patients following elective percutaneous coronary interventions or an acute coronary syndrome (ACS), e. g. ST elevation myocardial infarction, non-ST elevation myocardial infarction and unstable angina.
Literaturnachweis: European Heart Journal doi:10.1093/eurheartj/ehx419. Download (www.escardio.org). Autoren: Marco Valgimigli (Chairperson) (Switzerland), Hector Bueno (Spain), Robert A. Byrne (Germany), Jean-Philippe Collet (France), Francesco Costa (Italy), Anders Jeppsson1 (Sweden), Peter Juni (Canada),
14 Jan 2018 The scope of the 2017 European Society of Cardiology (ESC) focused update on dual antiplatelet therapy (DAPT) in coronary artery disease (CAD) developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), which is published in this issue of the journal, is to address recommendations on
ESC Guideline Update on Dual Antiplatelet Therapy in CAD. Sue Hughes. September 14, 2017. BARCELONA, SPAIN — The European Society of Cardiology has issued a new "focused update" on its guidelines on dual antiplatelet therapy (DAPT)—aspirin plus a P2Y12 inhibitor—in coronary artery disease (CAD).
2017 Focused update on Dual Antiplatelet Therapy (DAPT). ESC Clinical Practice Guidelines. Topic(s):. Myocardial Disease. Cardiovascular Pharmacotherapy. Acute Coronary Syndromes. Guidelines version available to download. Full text. Published in 2017. Reference European Heart Journal, Volume 39, Issue 3,
Annons